Monitoring of blood levels in patients administered CYP3A4 inhibitor during the maintenance phase of venetoclax administrationâ©.

Kubo, Toshiki; Matsuo, Shunsuke; Sogawa, Rintaro; Yasu, Takeo; Nagaie, Toshiaki; Okamoto, Sho; Kimura, Shinya; Shimanoe, Chisato

Monitoring of blood levels in patients administered CYP3A4 inhibitor during the maintenance phase of venetoclax administrationâ©.

Kubo, Toshiki; Matsuo, Shunsuke; Sogawa, Rintaro; Yasu, Takeo; Nagaie, Toshiaki; Okamoto, Sho; Kimura, Shinya; Shimanoe, Chisato.

Int J Clin Pharmacol Ther ; 62(1): 56-60, 2024 Jan.

Article in En | MEDLINE | ID: mdl-37969095

Subject(s)

Antineoplastic Agents; Cytochrome P-450 CYP3A Inhibitors; Male; Humans; Adult; Antineoplastic Agents/adverse effects; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cytochrome P-450 CYP3A

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytochrome P-450 CYP3A Inhibitors / Antineoplastic Agents Limits: Adult / Humans / Male Language: En Journal: Int J Clin Pharmacol Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Type: Article

Fulltext

XML

PubMed Links

Search on Google